Results 171 to 180 of about 73,700 (231)

Pharmacodynamics of Camizestrant Treatment in Postmenopausal Women With Estrogen Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Primary Breast Cancer: Results From the Randomized, Presurgical SERENA-3 Study. [PDF]

open access: yesJ Clin Oncol
Robertson JFR   +16 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy